Sleep-disordered breathing (SDB), ranging from habitual snoring to severe obstructive sleep apnea (OSA), is highly prevalent ...

LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today hosted its 2025 Investor Day and presented its comprehensive strategic roadmap and long-range financial plan.

New research reveals insomnia's deep links to cardiovascular health, urging us to treat it as a core medical issue, not a ...

ResMed faces an uncertain future as GLP-1 weight loss drugs threaten to reduce demand for sleep apnea devices, creating a complex investment dilemma for shareholders of the CPAP machine leader.

Obstructive sleep apnea (OSA), a global public health issue marked by repeated upper airway collapse during sleep, is tied to diverse diseases-from cardiovascular conditions to cancer.

Postmenopausal women are especially vulnerable to hypertension, which is a major cardiovascular risk factor. Women ...

Daybreak, a provider of fully at-home sleep apnea diagnosis and treatment, has named Robert Miller, RPSGT, as its new senior vice president of commercial strategy.

The 1945 “whole-person” formula used by the Department of Veterans Affairs presumes independence among various disabilities. But empirical data show that this assumption is faulty, and veterans ...

Another point to raise with patients is when they are taking the supplement. “Melatonin also must be carefully timed. If it ...

Submission of New Drug Application (NDA) for lorundrostat planned for late-2025/Q1 2026 –– Completed enrollment in Explore-OSA trial; topline ...

The use of electrical stimulation of the upper airway to treat patients with obstructive sleep apnea (OSA) is supported by low-quality evidence.